Hikma Pharmaceuticals (HIK)

 

HIK Share PerformanceMore

52 week high2,703.0 02/08/16
52 week low1,575.0 04/11/16
52 week change -468.0 (-20.26%)
4 week volume13,237,204 29/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 1623D Hikma Pharmaceuticals Plc 24 April 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Mary Regina (Nina) Henderson 2 Reason for the notification a) Position/status Non-Executive Director b)...

Director/PDMR Shareholding

RNS Number: 4403C Hikma Pharmaceuticals Plc 13 April 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Michael Raya 2 Reason for the notification a) Position/status CEO of West-Ward Pharmaceuticals b) Initia...

Director/PDMR Shareholding

RNS Number: 4388C Hikma Pharmaceuticals Plc 13 April 2017 Hikma Pharmaceuticals PLC - EIP Awards LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional awards and nil cost options under the Hikma Pharmaceuticals PLC 2014 Executive Incenti...

Director/PDMR Shareholding

RNS Number: 4387C Hikma Pharmaceuticals Plc 13 April 2017 Hikma Pharmaceuticals PLC - EIP Awards LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional awards and nil cost option under the Hikma Pharmaceuticals PLC 2014 Executive Incentiv...

Director/PDMR Shareholding

RNS Number: 4386C Hikma Pharmaceuticals Plc 13 April 2017 Hikma Pharmaceuticals PLC - EIP Awards LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional awards and nil cost option under the Hikma Pharmaceuticals PLC 2014 Executive Incentiv...

Director/PDMR Shareholding

RNS Number: 4385C Hikma Pharmaceuticals Plc 13 April 2017 Hikma Pharmaceuticals PLC - EIP Awards LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional awards and nil cost option under the Hikma Pharmaceuticals PLC 2014 Executive Incentiv...

Director/PDMR Shareholding

RNS Number: 2382C Hikma Pharmaceuticals Plc 11 April 2017 Hikma Pharmaceuticals PLC - Vesting of 2014 EIP LONDON, 11 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (" Hikma ") announces that the following Persons Discharging Managerial Responsibility (" PDMR ") have received shares as a result of the vesting of their condition...

Cheap commodities drag miners lower

A slump in gold, copper and iron prices kept miners among the top fallers and prevented the FTSE 100 from gaining positi...

Fundamental DataMore

P/E ratio27.699
EPS66.5
Dividend yield1.792 %

Latest discussion posts More

  • Re: UpDown

    At what point will this become a screaming buy? Some good news on the Advair generic would stop the rot, but that's probably at least a month away......
    7-Apr-2017
    sapito
  • Re: UpDown

    "3 reasons for fall" "dir sale 43k " - valid, but after the amount of shares bought by directors over the winter, as has been pointed out, this is minute. And it was falling ...
    24-Mar-2017
    Hardboy
  • Re: UpDown

    This time last year,HIK dropped to around #16 after results and I bought in.Unfortunately it marched all the way up to about #25 and I didn't take profit and it came back ...
    24-Mar-2017
    bamboozled

Users' HoldingsMore

Users who hold Hikma Pharmaceuticals also hold..
LLOYDS GRP.30%
GLAXOSMITHKLINE29%
RDS 'B'27%
BP25%
VODAFONE GRP.24%

Codes & Symbols

ISINGB00B0LCW083
SymbolsHIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK